Quantitation of whole blood Epstein-Barr virus DNA is useful for assessing treatment response in patients with non-Hodgkin's lymphoma

International Journal of Laboratory Hematology

Volumn 32, Issue 1 PART.1, 2010, Pages

  Jo, S A ^a   Hwang, S H ^a,b   Kim, S Y ^a   Shin, S Y ^a   Chung, J S ^a   Sol, M Y ^a   Chang, C L ^a,b   Lee, E Y ^a,b  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

Ebv; Epstein barr virus; Nhl; Non hodgkin's lymphoma; Real time pcr; Whole blood

Indexed keywords

ANTINEOPLASTIC AGENT; VIRUS DNA;

ADULT; ARTICLE; B CELL LYMPHOMA; BLOOD SAMPLING; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT RESPONSE; VIRUS LOAD;

BIOLOGICAL MARKERS; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 77249135969     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553x.2009.0117l.x     Document Type: Article

References (26)

1. Anonymous (1993) A predictive model for aggressive non-Hodgkin's lym- phoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. The New England Journal of Medicine 329, 987-994.
2. Au W.Y., Pang A., Choy C., Chim C.S. & Kwong Y.L. (2004) Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 104, 243-249.
3. Bonnet F., Jouvencel A.C., Parrens M., Leon M.J., Cotto E., Garrigue I., Morlat P., Beylot J., Fleury H. & Lafon M.E. (2006) A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma. Journal of Clinical Virology 36, 258-263.
4. Cheson B.D., Pfistner B., Juweid M.E., Gascoyne R.D., Specht L., Horning S.J., Coiffier B., Fisher R.I., Hagenbeek A., Zucca E., Rosen S.T., Stroobants S., Lister T.A., Hoppe R.T., Dreyling M., Tobinai K., Vose J.M., Connors J.M., Federico M. & Diehl V. (2007) Revised response criteria for malignant lymphoma. Journal of Clinical Oncology 25, 579-586.
5. Fafi-Kremer S., Brengel-Pesce K., Bargues G., Bourgeat M.J., Genoulaz O., Seigneurin J.M. & Morand P. (2004) Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma. Journal of Clinical Virology 30, 157-164.
6. Fan H., Kim S.C., Chima C.O., Israel B.F., Lawless K.M., Eagan P.A., Elmore S., Moore D.T., Schichman S.A., Swinnen L.J. & Gulley M.L. (2005) Epstein-Barr viral load as a marker of lymphoma in AIDS patients. Journal of Medical Virology 75, 59-69.
7. Gandhi M.K., Lambley E., Burrows J., Dua U., Elliott S., Shaw P.J., Prince H.M., Wolf M., Clarke K., Underhill C., Mills T., Mollee P., Gill D., Marlton P., Seymour J.F. & Khanna R. (2006) Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV- positive Hodgkin's lymphoma. Clinical Cancer Research 12, 460-464.
8. Gulley M.L. (2001) Molecular diagnosis of Epstein-Barr virus-related diseases. Journal of Molecular Diagnostics 3, 1-10.
9. Heslop H.E. (2005) Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas. Hematology American Society of Hematology Education Program, 260-266.
10. Hsieh P.P., Tung C.L., Chan A.B., Liao J.B., Wang J.S., Tseng H.H., Su H.H., Chang K.C. & Chang C.C. (2007) EBV viral load in tumor tissue is an important prognostic indicator for nasal NK/ T-cell lymphoma. American Journal of Clinical Pathology 128, 579-584.
11. Jaffe E.S., Harris N.L., Stein H. & Vordiman J.W. (2001) Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours. IARC Press, Lyon.
12. Jarrett R.F. (2003) Risk factors for Hodgkin's lymphoma by EBV status and significance of detection of EBV genomes in serum of patients with EBV-associ- ated Hodgkin's lymphoma. Leukemia & Lymphoma 44(Suppl 3), S27-S32.
13. Kawa K. (2000) Epstein-Barr virus: associated diseases in humans. International Journal of Hematology 71, 108-117.
14. Leung S.F., Chan A.T., Zee B., Ma B., Chan L.Y., Johnson P.J. & Lo Y.M. (2003) Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type. Cancer 98, 288-291.
15. Lit L.C., Chan K.C., Leung S.F., Lei K.I., Chan L.Y., Chow K.C., Chan A.T. & Lo Y.M. (2004) Distribution of cell-free and cell-associated Epstein-Barr virus (EBV) DNA in the blood of patients with nasopharyngeal carcinoma and EBV-associated lymphoma. Clinical Chemistry 50, 1842-1845.
16. Lo Y.M., Chan L.Y., Chan A.T., Leung S.F., Lo K.W., Zhang J., Lee J.C., Hjelm N.M., Johnson P.J. & Huang D.P. (1999a) Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Research 59, 5452-5455.
17. Lo Y.M., Chan L.Y., Lo K.W., Leung S.F., Zhang J., Chan A.T., Lee J.C., Hjelm N.M., Johnson P.J. & Huang D.P. (1999b) Quantitative analysis of cell- free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Research 59, 1188-1191.
18. Niesters H.G., van Esser J., Fries E., Wolthers K.C., Cornelissen J. & Osterhaus A.D. (2000) Development of a real-time quantitative assay for detection of Epstein-Barr virus. Journal of Clinical Microbiology 38, 712-715.
19. Park S., Lee J., Ko Y.H., Han A., Jun H.J., Lee S.C., Hwang I.G., Park Y.H., Ahn J.S., Jung C.W., Kim K., Ahn Y.C., Kang W.K., Park K. & Kim W.S. (2007) The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood 110, 972-978.
20. Prang N.S., Hornef M.W., Jager M., Wagner H.J., Wolf H. & Schwarzmann F.M. (1997) Lytic replication of Epstein- Barr virus in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state. Blood 89, 1665-1677.
21. Suwiwat S., Pradutkanchana J., Ishida T. & Mitarnun W. (2007) Quantitative analysis of cell-free Epstein-Barr virus DNA in the plasma of patients with peripheral T-cell and NK-cell lymphomas and peripheral T-cell proliferative diseases. Journal of Clinical Virology 40, 277-283.
22. Tierney R.J., Steven N., Young L.S. & Rickinson A.B. (1994) Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. Journal of Virology 68, 7374-7385.
23. To E.W., Chan K.C., Leung S.F., Chan L.Y., To K.F., Chan A.T., Johnson P.J. & Lo Y.M. (2003) Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma. Clinical Cancer Research 9, 3254-3259.
24. Wagner H.J., Jabs W., Smets F., Wessel M., Fischer L., Offner G., Kirchner H. & Bucsky P. (2000) Real-time polymerase chain reaction (RQ-PCR) for the monitoring of Epstein-Barr virus (EBV) load in peripheral blood mononuclear cells. Klinische Padiatrie 212, 206-210.
25. Wagner H.J., Schlager F., Claviez A. & Bucsky P. (2001) Detection of Epstein- Barr virus DNA in peripheral blood of paediatric patients with Hodgkin's disease by real-time polymerase chain reaction. European Journal of Cancer 37, 1853-1857.
26. Wagner H.J., Fischer L., Jabs W.J., Holbe M., Pethig K. & Bucsky P. (2002) Longitudinal analysis of Epstein-Barr viral load in plasma and peripheral blood mononuclear cells of transplanted patients by real-time polymerase chain reaction. Transplantation 74, 656-664.